cancer
Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal

Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal

Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly US$ 40 billion.

Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal
IHSG
6.911,73
0.31%
21,16
LQ45
952,80
1.04%
9,76
USD/IDR
14.868
-0,82
EMAS
1.014.000
0,00%